Dosing
Stronger Heart: In PROVE-HF, LVEF increased from 28.2% to 37.8% in patients with HFrEF treated with ENTRESTO ® at 12 months (difference, 9.4% [95% CI, 8.8% to 9.9%]; P < .001).1 Stronger Life: In...
- Twitter Linkedin Facebook Pinterest Google plus
Mechanism of Action
Stronger Heart: In PROVE-HF, LVEF increased from 28.2% to 37.8% in patients with HFrEF treated with ENTRESTO ® at 12 months (difference, 9.4% [95% CI, 8.8% to 9.9%]; P < .001).1 Stronger Life: In...
Twitter Linkedin Facebook Pinterest Google plusTraining/Video
MPN10 - Symptoomzoeker
Download Dutch documentMPN10 - Connaissez votre score
Download French documentHighlights From ASCO 2022
Ribociclib Breast Cancer Presentations
MONALEESA-2 OS BY DOSE REDUCTION poster discussion | Hart LL In this exploratory analysis of ML-2, 1L RIB + LET maintained OS benefit in postmenopausal pts with HR+, HER2...Twitter Linkedin Facebook Pinterest Google plusIndications
Stronger Heart: In PROVE-HF, LVEF increased from 28.2% to 37.8% in patients with HFrEF treated with ENTRESTO ® at 12 months (difference, 9.4% [95% CI, 8.8% to 9.9%]; P < .001).1 Stronger Life: In...
Twitter Linkedin Facebook Pinterest Google plusJakavi®: PV Patient Brochure (Dutch)
Informatie omtrent de oorzaken, symptomen en leven met PV Download Dutch documentMF: patient brochure (NL)
Download Dutch documentJakavi®: PV Patient Brochure (French)
Information sur les causes, les symptômes de la MV et conseils pour mieux vivre avec celle-ci Download French document
×